Arzu Akyay

Arzu Akyay

Auto-generated profile, based on publicly available information

Arzu Akyay

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, İnönü University, 44280 Malatya, Türkiye

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2021 in Pediatric Blood & Cancer
Verified
Journal Article
Open access
PDF file
RKRejin Kebudi
Rejin Kebudi
NKNilgün Kurucu
Nilgün Kurucu
DTDeniz Tuğcu
Deniz Tuğcu
ŞHŞadan Hacısalihoğlu
Şadan Hacısalihoğlu
TFTunç Fışgın
Tunç Fışgın
AKAteş Kara
Ateş Kara
Click on the article title to read more.

24 February 2022 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
PDF file
MYM. Akif Yesilipek
M. Akif Yesilipek
VUVedat Uygun
Vedat Uygun
AKAlphan Kupesiz
Alphan Kupesiz
GKGulsun Karasu
Gulsun Karasu
GOGulyuz Ozturk
Gulyuz Ozturk
AAAli Bülent Antmen
Ali Bülent Antmen

24 February 2022 in Turkish Journal of Hematology
Verified
Journal Article
Open access
SBSinem Civriz Civriz Bozdag
Sinem Civriz Civriz Bozdag
GSGuldane Cengiz Seval
Guldane Cengiz Seval
IYIpek Yonal-Hindilerden
Ipek Yonal-Hindilerden
FHFehmi Hindilerden
Fehmi Hindilerden
NANeslihan Andıç
Neslihan Andıç
GÖGüner Hayri Özsan
Güner Hayri Özsan
Objective: Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly immunosuppressed populations, such as in patients with hematological malignancies, is a point of interest. We aimed to analyze the symptoms, complications, intensive care unit admissions, and mortality rates of patients with hematological malignancies infected with SARS-CoV-2 in Turkey. Materials and Methods: In this multicenter study, we included 340 adult and pediatric patients diagnosed with SARS-CoV-2 from March to November 2020. Diagnosis and status of primary disease, treatment schedules for hematological malignancies, time from last treatment, life expectancy related to the hematological disease, and comorbidities were recorded, together with data regarding symptoms, treatment, and outcome of SARS-CoV-2 infection. Results: Forty four patients were asymptomatic at diagnosis of SARSCoV-2 infection. Among symptomatic patients, fever, cough, and dyspnea were observed in 62.6%, 48.8%, and 41.8%, respectively. Sixtynine (20%) patients had mild SARS-CoV-2 disease, whereas moderate, severe, and critical disease was reported in 101 (29%), 71 (20%), and 55 (16%) patients, respectively. Of the entire cohort, 251 (73.8%) patients were hospitalized for SARS-CoV-2. Mortality related to SARS-CoV-2 infection was 26.5% in the entire cohort; this comprised 4.4% of those patients with mild disease, 12.4% of those with moderate disease, and 83% of those with severe or critical disease. Active hematological disease, lower life expectancy related to primary hematological disease, neutropenia at diagnosis of SARS-CoV-2, ICU admission, and first-line therapy used for coronavirus disease-2019 treatment were found to be related to higher mortality rates. Treatments with hydroxychloroquine alone or in combination with azithromycin were associated with a higher rate of mortality in comparison to favipiravir use. Conclusion: Patients with hematological malignancy infected with SARS-CoV-2 have an increased risk of severe disease and mortality.

1 January 2013 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
AAArzu Akyay
Arzu Akyay
GCGülçin Cihangiroglu
Gülçin Cihangiroglu
YÖYusuf Özkan
Yusuf Özkan
UDUğur Deveci
Uğur Deveci
SBSemiha Bahceci
Semiha Bahceci
ZÇZiya Çetinkaya
Ziya Çetinkaya
Primary hyperparathyroidism (PHP) and myelofibrosis are rare entities in childhood. Myelofibrosis secondary to PHP is also extremely rare. We report a 15-year-old boy presented with generalized weakness, vomiting, and pallor. A parathyroid adenoma was detected on the left distal parathyroid gland. PHP was diagnosed together with hepatosplenomegaly and pancytopenia. Bone marrow biopsy revealed grade 3–4 reticulin fibrosis. As early as 2 months after the left distal parathyroidectomy, hematologic parameters improved without any other intervention. His liver and spleen also gradually decreased in size. We concluded that the pancytopenia was as a result of myelofibrosis from PHP.

17 May 2023 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
ZGZeliha Guzelkucuk
Zeliha Guzelkucuk
DKDeniz Yılmaz Karapınar
Deniz Yılmaz Karapınar
SGSema Aylan Gelen
Sema Aylan Gelen
HTHuseyin Tokgoz
Huseyin Tokgoz
AOAlper Ozcan
Alper Ozcan
MEMelike Sezgin Evim
Melike Sezgin Evim

25 October 2012 in Pediatric Hematology and Oncology
Verified
Journal Article
Closed access
AAArzu Akyay
Arzu Akyay
ÖSÖzgen ARSLAN SOLMAZ
Özgen ARSLAN SOLMAZ